A Tale of Two Spirochetes: Lyme Disease and Syphilis

Neurologic Clinics

Volumn 28, Issue 1, 2010, Pages 277-291

  Halperin, John J ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b OVERLOOK HOSPITAL   (United States)

Author keywords

Lyme disease; Neuroborreliosis; Neurosyphilis; Syphilis

Indexed keywords

AMOXICILLIN; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME AXETIL; DOXYCYCLINE; PENICILLIN G; PROBENECID; PROCAINE PENICILLIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL IMMUNITY; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; BORRELIA BURGDORFERI; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG EFFICACY; DRUG RESPONSE; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INCIDENCE; LYME DISEASE; NEUROSYPHILIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SINGLE DRUG DOSE; TREPONEMA PALLIDUM; VENEREAL DISEASE REACTION TEST;

HUMANS; LYME DISEASE; LYME NEUROBORRELIOSIS; NEUROSYPHILIS; SPIROCHAETALES; SPIROCHAETALES INFECTIONS; SYPHILIS;

EID: 70449633243     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ncl.2009.09.009     Document Type: Review

References (46)

1. Steere A.C., Malawista S.E., Hardin J.A., et al. Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum. Ann Intern Med 86 6 (1977) 685-698
2. Fingerle V., Schulte-Spechtel U.C., Ruzic-Sabljic E., et al. Epidemiological aspects and molecular characterization of Borrelia burgdorferi s.l. from southern Germany with special respect to the new species Borrelia spielmanii sp. nov. Int J Med Microbiol 298 (2008) 279-290
3. Benach J.L., Bosler E.M., Hanrahan J.P., et al. Spirochetes isolated from the blood of two patients with Lyme disease. N Engl J Med 308 (1983) 740-742
4. Steere A.C., Grodzicki R.L., Kornblatt A.N., et al. The spirochetal etiology of Lyme disease. N Engl J Med 308 (1983) 733-740
5. Asbrink E., Hederstedt B., and Hovmark A. The spirochetal etiology of acrodermatitis chronica atrophicans Herxheimer. Acta Derm Venereol 64 (1984) 506-512
6. Bannwarth A. Chronische lymphocytare meningitis, entzundliche polyneuritis und "rheumatismus". Arch Psychiatr Nervenkr 113 (1941) 284-376
7. Wormser G.P., Dattwyler R.J., Shapiro E.D., et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 43 (2006) 1089-1134
8. Gerber M.A., Shapiro E.D., Burke G.S., et al. Lyme disease in children in southeastern Connecticut. Pediatric Lyme Disease Study Group. N Engl J Med 335 17 (1996) 1270-1274
9. Reik L., Steere A.C., Bartenhagen N.H., et al. Neurologic abnormalities of Lyme disease. Medicine 58 4 (1979) 281-294
10. Avery R.A., Frank G., and Eppes S.C. Diagnostic utility of Borrelia burgdorferi cerebrospinal fluid polymerase chain reaction in children with Lyme meningitis. Pediatr Infect Dis J 24 8 (2005) 705-708
11. Tugwell P., Dennis D.T., Weinstein A., et al. Laboratory evaluation in the diagnosis of Lyme Disease. Ann Intern Med 127 (1997) 1109-1123
12. Kaell A.T., Volkman D.J., Gorevic P.D., et al. Positive Lyme serology in subacute bacterial endocarditis. A study of four patients. JAMA 264 22 (1990) 2916-2918
13. Centers for Disease Control and Prevention (CDC). Recommendations for test performance and interpretation from the Second National Conference on serologic diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep 44 31 (1995) 590-591
14. Halperin J., Logigian E., Finkel M., et al. Practice parameter for the diagnosis of patients with nervous system Lyme borreliosis (Lyme disease). Neurology 46 (1996) 619-627
15. Hammers Berggren S., Hansen K., Lebech A.M., et al. Borrelia burgdorferi-specific intrathecal antibody production in neuroborreliosis: a follow-up study. Neurology 43 1 (1993) 169-175
16. Ljostad U., Skarpaas T., and Mygland A. Clinical usefulness of intrathecal antibody testing in acute Lyme neuroborreliosis. Eur J Neurol 14 8 (2007) 873-876
17. Blanc F., Jaulhac B., Fleury M., et al. Relevance of the antibody index to diagnose Lyme neuroborreliosis among seropositive patients. Neurology 69 10 (2007) 953-958
18. Garin C., and Bujadoux A. Paralysie par les tiques. [Paralysis by ticks]. J Med Lyon 71 (1922) 765-767 [in French]
19. Steere A.C., Pachner A.R., and Malawista S.E. Neurologic abnormalities of Lyme disease: successful treatment with high-dose intravenous penicillin. Ann Intern Med 99 (1983) 767-772
20. Shah S.S., Zaoutis T.E., Turnquist J., et al. Early differentiation of Lyme from enteroviral meningitis. Pediatr Infect Dis J 24 6 (2005) 542-545
21. Garro A.C., Rutman M., Simonsen K., et al. Prospective validation of a clinical prediction model for Lyme meningitis in children. Pediatrics 123 5 (2009) e829-e834
22. Halperin J.J. Diagnosis and treatment of the neuromuscular manifestations of Lyme disease. Curr Treat Options Neurol 9 2 (2007) 93-100
23. Halperin J.J., Luft B.J., Volkman D.J., et al. Lyme neuroborreliosis-peripheral nervous system manifestations. Brain 113 (1990) 1207-1221
24. Muley S.A., and Parry G.J. Antibiotic responsive demyelinating neuropathy related to Lyme disease. Neurology 72 20 (2009) 1786-1787
25. Halperin J.J., Krupp L.B., Golightly M.G., et al. Lyme borreliosis-associated encephalopathy. Neurology 40 (1990) 1340-1343
26. Luo N., Johnson J., Shaw J., et al. Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and Health Utilities Index. Med Care 43 11 (2005) 1078-1086
27. Kalina P., Decker A., Kornel E., et al. Lyme disease of the brainstem. Neuroradiology 47 12 (2005) 903-907
28. Logigian E.L., Johnson K.A., Kijewski M.F., et al. Reversible cerebral hypoperfusion in Lyme encephalopathy. Neurology 49 6 (1997) 1661-1670
29. Halperin J.J., Shapiro E.D., Logigian E.L., et al. Practice parameter: treatment of nervous system Lyme disease. Neurology 69 1 (2007) 91-102
30. Klempner M., Hu L., Evans J., et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 345 (2001) 85-92
31. Krupp L.B., Hyman L.G., Grimson R., et al. Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology 60 12 (2003) 1923-1930
32. Fallon B, Sackheim H, Keil J, et al. Double-blind placebo-controlled retreatment with IV ceftriaxone for Lyme encephalopathy: clinical outcome. Paper presented at the 10th International Conference on Lyme Borreliosis and other tick-borne diseases. Vienna, Austria, September 11-15, 2005.
33. Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2007 supplement, syphilis surveillance report (2009), U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta (GA)
34. Bacon R.M., Kugeler K.J., and Mead P.S. Surveillance for Lyme disease - United States, 1992-2006. MMWR Morb Mortal Wkly Rep 57 SS10 (2008) 1-9
35. Martin I.E., Lau A., Sawatzky P., et al. Serological diagnosis of syphilis: enzyme-linked immunosorbent assay to measure antibodies to individual recombinant Treponema pallidum antigens. J Immunoassay Immunochem 29 2 (2008) 143-151
36. Lessig S., and Tecoma E. Perils of the prozone reaction: neurosyphilis presenting as an RPR-negative subacute dementia. Neurology 66 (2006) 777
37. Marra C.M., Critchlow C.W., Hook III E.W., et al. Cerebrospinal fluid treponemal antibodies in untreated early syphilis. Arch Neurol 52 1 (1995) 68-72
38. Marra C., Tantalo L., Maxwell C., et al. Alternative cerebrospinal fluid tests to diagnose neurosyphilis in HIV-infected individuals. Neurology 63 (2004) 85-88
39. Flood J.M., Weinstock H.S., Guroy M.E., et al. Neurosyphilis during the AIDS epidemic, San Francisco, 1985-1992. J Infect Dis 177 4 (1998) 931-940
40. Katz D.A., and Berger J.R. Neurosyphilis in acquired immunodeficiency syndrome. Arch Neurol 46 8 (1989) 895-898
41. Hook III E.W., and Chansolme D. Neurosyphilis. In: Roos K.L. (Ed). Principles of neurological infectious diseases (2005), McGraw Hill Medical Publishing Division, New York 215-231
42. Flint A., Liberato B., Anziska Y., et al. Meningovascular syphilis as a cause of basilar artery stenosis. Neurology 64 (2005) 391-392
43. Sonoo M., Katayama A., Miura T., et al. Tibial nerve SEPs localized the lesion site in a patient with early tabes dorsalis. Neurology 64 (2005) 1452-1454
44. Workowski K., and Berman S. Sexually transmitted diseases treatment guidelines, 2006. MMWR Morb Mortal Wkly Rep 55 RR-11 (2006) 22-35
45. Jay C.A. Treatment of neurosyphilis. Curr Treat Options Neurol 8 3 (2006) 185-192
46. Gordon S., Eaton M., George R., et al. The response of symptomatic neurosyphilis to high-dose intravenous penicillin G in patients with human immunodeficiency virus infection. N Engl J Med 331 (1994) 1469-1473